Updated hourlyHourly refreshSun, Sep 20, 2026
Press Release Database
Recent press releases, indexed by topic.
Finance · Healthcare
(PR-inside.com) Advances GelrinC® U.S. pivotal trial with 43 patients treated; Completion of enrollment expected by approximately year end 2026 Expands European commercialization readiness, including surgeon training and regulatory approval of new manufacturing process that improves production yield 400% Strengthened balance sheet with $6.5 million private placement in June 2026 HERZLIYA, IL / ACCESS Newswire / September 11, 2026 / Regentis Biomaterials Ltd. ("Regentis" or the "Company") (NYSE American:RGNT), a regenerative medicine company focused on innovative tissue repair solutions, today reported financial results for the six months ended June 30, 2026 and provided a corporate and clinical update. "During the first half of 2026, we continued ..
Sep 11 · 13:00·PR-Inside
Finance · Healthcare
King of Prussia, Pennsylvania--(Newsfile Corp. - September 11, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company developing therapeutics based on its proprietary INTASYL® siRNA gene-silencing technology designed to eliminate cancer, today announced that members of its management team will be available for one-on-one investor meetings at the H.C. Wainwright 28th Annual Global Investment Conference, taking place September 14-16, 2026, at the Lotte New York...
Sep 11 · 13:00·mlpr-newsfile
SaaS · Healthcare
(PR-inside.com) After Agricultural Demos, Company Maps a Parallel Path for Custom Kitchen Demonstrations Across Commercial Kitchens and Multi-Unit Operators MESA, AZ / ACCESS Newswire / September 11, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today announced further progress on StrainScan Pro's foodservice application, advancing the platform from market positioning into a custom demonstration path for commercial kitchens and multi-unit operators. The platform is live at https://strainscanpro.com . Foodservice has already been identified as a core StrainScan Pro vertical alongside agriculture. The Company is now taking the same next step it recently took on the farm side: putting the software in front of operators. After ..
Sep 11 · 12:57·PR-Inside
Healthcare
After Agricultural Demos, Company Maps a Parallel Path for Custom Kitchen Demonstrations Across Commercial Kitchens and Multi-Unit Operators
Sep 11 · 12:57·Newswire.com
Healthcare · Education
New study finds that mRNA vaccination sustained influenza-specific germinal-center activity for up to six months in some participants SEOUL, South Korea, Sept. 11, 2026 /PRNewswire/ -- Influenza remains a major global health challenge as continual antigenic drift can limit the breadth and...
Sep 11 · 12:48·PR Newswire
Finance · Healthcare
HOUSTON, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that its pre-recorded presentation from the H.C. Wainwright 28th Annual Global Investment Conference is now available for on-demand viewing here .
Sep 11 · 12:30·GlobeNewswire
Finance · SaaS
NEW YORK, Sept. 11, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Quantum BioPharma Ltd. (NASDAQ: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand Portfolio @ IBN ( InvestorBrandNetwork ) , a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.
Sep 11 · 12:30·GlobeNewswire
Healthcare
Transaction Establishes RWB in Germany and the United Kingdom, Two of Europe’s Most Important Medical Cannabis Markets
Sep 11 · 12:30·GlobeNewswire
Finance · Healthcare
INDIANAPOLIS, Sept. 11, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its third quarter 2026 financial results on Friday, November 6, 2026. Elanco will also conduct a conference call on that day with the investment community and media to further detail...
Sep 11 · 11:58·PR Newswire
Healthcare
(PR-inside.com) OMCAZIO approved for administration without regard to food, removing strict fasting requirements for cabozantinib patients SAN JOSE, CA AND TAIPEI, TW / ACCESS Newswire / September 11, 2026 / Handa Pharmaceuticals, Inc. ("Handa" or the "Company") (TSE:6620) announced that the U.S. Food and Drug Administration ("FDA") has granted final approval to OMCAZIO™ (cabozantinib) capsules, the laurylsulfate salt formulation of cabozantinib developed by the Company's U.S. subsidiary, Handa Oncology, LLC. The action converts Handa's prior tentative approval to final approval and authorizes OMCAZIO for commercialization in the United States. "Final approval from the FDA is a landmark milestone for Handa and reflects our ..
Sep 11 · 11:30·PR-Inside
Healthcare
Shanghai, China--(Newsfile Corp. - September 11, 2026) - On August 4, the 20th Frost & Sullivan Global Growth, Innovation and Leadership (GIL) Summit and the 5th New Investment Event (the "2026 Frost & Sullivan New Investment Event") officially opened at Jing An Shangri-La, Shanghai.In conjunction with the Summit, the Celebratory Banquet for the 65ᵗʰ Anniversary of Frost & Sullivan Global and the 20ᵗʰ Anniversary of the GIL Summit in China was held, where the 2026 Frost & Sullivan Global Awards...
Sep 11 · 11:28·mlpr-newsfile
Healthcare
A pharmaceutical product cannot reach the patient safely through formulation alone. Before a tablet, vaccine, biologic, or injectable reaches the market, it must pass through [read full press release...]
Sep 11 · 11:25·Express Press Release